a significant trendP = 0.0001
However, this study showed a significant trend towards a shorter DS duration when adding adjuvant chemotherapy to ATRA/ATO therapy (P = 0.0001), especially when used earlier in the onset of DS ( Figure 4 ).
However, this study showed a significant trend towards a shorter DS duration when adding adjuvant chemotherapy to ATRA/ATO therapy (P = 0.0001), especially when used earlier in the onset of DS ( Figure 4 ).